Search
for

    Sort by

    Research 601–630 of 1000+

    1. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104‐week open‐label clinical trial Journal of The European Academy of Dermatology and Venereology · 2015 · 20 citations
    2. Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis Clinical Cosmetic and Investigational Dermatology · 2019 · 9 citations
    3. Stability of minoxidil in Espumil foam base. PubMed · 2013 · 4 citations
    4. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss. PubMed · 2016 · 1 citations
    5. Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. PubMed · 2016 · 1 citations
    6. 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis 2019
    7. New possibilities extemporaneous preparation in dermatology - innovative foam base Espumil Dermatologie pro praxi · 2016
    8. Faculty Opinions recommendation of Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2016
    9. Effectiveness of once daily 5% minoxidil topical foam in the treatment of women with thinning hair due to female pattern hair loss (FPHL) Journal of The American Academy of Dermatology · 2015
    10. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men Journal of The American Academy of Dermatology · 2007 · 142 citations
    11. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women Journal of The American Academy of Dermatology · 2011 · 100 citations
    12. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial International Journal of Dermatology · 2003 · 66 citations
    13. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women Dermatologic Surgery · 2019 · 22 citations
    14. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis British Journal of Dermatology · 2014 · 19 citations
    15. Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2016 · 4 citations
    16. Minoxidil topical foam: A new kid on the block International journal of trichology · 2009 · 4 citations
    17. Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia. PubMed · 2016 · 3 citations
    18. Rabbit syndrome because of topical minoxidil foam Dermatologic Therapy · 2015 · 2 citations
    19. Gender based price differences in 5% minoxidil foam: The impact of generic alternatives and bulk packaging Dermatology Online Journal · 2026
    20. Effectiveness of Chuzhi Shengfa Tablets Combined with Ketoconazole Shampoo and Chuzhi Shengfa Tablets Combined with 5% Minoxidil Foam in the Treatment of Male Androgenetic Alopecia Journal of Clinical and Nursing Research · 2024
    21. 5% Minoxidil topical foam on women: Menopause and other covariates Journal of The American Academy of Dermatology · 2019
    22. Comparison of a New 5% Minoxidil Foam and Rogaine® in the Treatment of Androgenetic Alopecia in Chinese Men: A Randomized, Double-Blind, Phase III, Equivalence Trial Dermatologic Therapy · 2023
    23. A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women Journal of The American Academy of Dermatology · 2019
    24. Faculty Opinions recommendation of A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2011
    25. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia Cell Cycle · 2017 · 12 citations
    26. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial Journal of the European Academy of Dermatology and Venereology · 2006 · 114 citations
    27. Follicular and percutaneous penetration pathways of topically applied minoxidil foam European Journal of Pharmaceutics and Biopharmaceutics · 2010 · 74 citations
    28. Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins SAGE Open Medical Case Reports · 2017 · 1 citations
    29. Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial Journal of Cosmetic Dermatology · 2021 · 4 citations
    30. ENHANCING THE PHYSICAL CHARACTERISTICS AND SHELF LIFE OF RICE WATER (ORYZA SATIVA L.) GEL SHAMPOO: THE ROLE OF PROPYLENE GLYCOL CONCENTRATION International Journal of Applied Pharmaceutics · 2024 · 1 citations